Institute of Molecular Physiology and Genetics
International grants
| Project CELGENE | |
| Principal Investigator: | Albert Breier (Contract with the Celgene company) |
| Duration: | 2009 – 2014 |
| P-glycoprotein Mediated Multidrug Resistance in Radiation-Associated Hematological Malignancies Following the Chernobil Accident | |
| Program: | NATO Grant PDD(CP)-(CBP.NUKR.CLG 982646) |
| Principal Investigator: | Albert Breier |
| Duration: | 2007 – 2008 |
Slovak Research and Development Agency (APVV):
| The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects | |
| Program: | APVV-16-0439 |
| Principal Investigator (FChPT STU): | Martin Šimkovič |
| Principal investigator at IMPG SAS: | Zdena Sulová |
| Duration: | 2017 – 2021 |
| Defense mechanisms of neoplastic cells against chemical stress | |
| Program: | APVV-15-0303 |
| Principal investigator (Faculty of Chemical and Food Technology STU in Bratislava): | Albert Breier |
| Principal investigator at IMPG SAS: | Zdena Sulová |
| Duration: | 2016 – 2020 |
| Novel synergistic antitumour properties of nuclear retinoid X receptor (RXR) agonists as a consequence of the conditional RXR-RAR heterodimer formation in human breast cancer cells | |
| Program: | APVV-15-0372 |
| Principal investigator (Institute of Experimental Endocrinology BMC SAS): | Július Brtko |
| Principal investigator at IMPG SAS: | Zdena Sulová |
| Duration: | 2016 – 2020 |
| Smart MoS2 platform for cancer diagnosis and targeted treatment | |
| Program: | APVV-15-0641 |
| Principal investigator (Institute of Physics SAS): | Peter Šiffalovič |
| Principal investigator at IMPG SAS: | Albert Breier |
| Duration: | 2016 – 2020 |
| Biochips and biosensors for glycorecognition, their development, preparation and application in cancer research | |
| Program: | APVV-14-0753 |
| Principal investigator (Institute of Chemistry, SAS): | Jaroslav Katrlík |
| Principal investigator at IMPG SAS: | Zdena Sulová |
| Duration: | 2015 – 2019 |
| Možná duálna funkcia P-glykoproteínu pri viacliekovej rezistencii leukemických buniek: efluxná pumpa a regulačný proteín | |
| Program: | APVV-14-0334 |
| Principal Investigator: | Zdena Sulová |
| Duration: | 2015 – 2018 |
| Preparation of nanostructured interfaces, their integration with bioelements and subsequent use | |
| Program: | APVV-0282-11 |
| Principal Investigator (Institute of Chemistry, SAS): | Ján Tkáč |
| Principal Investigator at IMPG SAS: | Zdena Sulová |
| Duration: | 2012 – 2015 |
| Antitumour effect of biologically active ligands of nuclear retinoid X receptor heterodimers in tissue carcinoma cell lines | |
| Program: | APVV-0160-11 |
| Principal Investigator (Institute of experimental Endocrinology, SAS): | Július Brtko |
| Principal Investigator at IMPG SAS: | Zdena Sulová |
| Duration: | 2012 – 2015 |
| Alteration in cell metabolism asocciated with drug transporter P-glycoprotein overexpression in leukemia cells | |
| Program: | APVV-0290-10 |
| Principal Investigator: | Zdena Sulová |
| Duration: | 2011 – 2014 |
| Overexpression of P-glycoprotein and associated changes in spectrum and levels oligo- and polysaccharides | |
| Program: | APVV-0084-07 |
| Principal Investigator: | Zdena Sulová |
| Duration: | 2008 – 2010 |
Grant Agency for Science (VEGA):
| The effect of polyphenols on the functions of signal proteins involved in proteins N-glycosylation in the endoplasmic reticulum of leukemia cells, depending on the expression of P-glycoprotein | |
| Program: | VEGA 2/0157/18 |
| Principal Investigator: | Viera Boháčová |
| Duration: | 2018 – 2021 |
| Analyses of allele-specific regulation of CD33 expression | |
| Program: | VEGA 2/0057/18 |
| Principal Investigator: | Jana Královičová |
| Duration: | 2018 – 2021 |
| Study of changes in expression of some regulatory and functional proteins connected with the presence of P-gp protein in leukemic cells | |
| Program: | VEGA 2/0122/17 |
| Principal Investigator: | Zdena Sulová |
| Duration: | 2017 – 2020 |
| The effect of endoplasmic reticulum stress inductors and proteaosome inhibitors on leukemia cell line L1210, SKM-1 and MOLM-13 with induced P-glycoprotein overexpression | |
| Program: | VEGA 2/0156/16 |
| Principal Investigator: | Mário Šereš |
| Duration: | 2016 – 2018 |
| Changes of leukemia cells drug sensitivity induced by changes of membrane drug transporters expression profile | |
| Program: | VEGA 2/0028/15 |
| Principal Investigator: | Albert Breier |
| Duration: | 2015 – 2018 |
| Multidrug resistance of leukemia cells on different drugs | |
| Program: | VEGA 2/0182/13 |
| Principal Investigator: | Zdena Sulová |
| Duration: | 2013 – 2016 |
| Overexpression of P-glycoprotein-induced cell changes in leukemia cells | |
| Program: | VEGA 2/0100/12 |
| Principal Investigator: | Albert Breier |
| Duration: | 2012 – 2014 |
| The effect of P-glycoprotein and development of multidrug resistance on some aspects of metabolism | |
| Program: | VEGA 2/0123/10 |
| Principal Investigator: | Zdena Sulová |
| Trvanie projektu: | 2010 – 2012 |
| Changes of leukemia cells associated with P-glycoprotein mediated multidrug resistance development | |
| Program: | VEGA 2/0155/09 |
| Principal Investigator: | Albert Breier |
| Duration: | 2009 – 2011 |